News
Most recent news regarding content, publications and engagement opportunities from the Centre.
-
-dusk-3-(low-res).jpg?sfvrsn=d03fd7ff_0)
Fellowship and Studentship Applications Now Open
April 18, 2018- Archive
The MGD CMCR is offering post doctoral fellowships and graduate trainee studentships. -
Medicinal marijuana is legal in most states (Rubin; JAMA)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Rubin R. Medical marijuana is legal in most states but physicians have little evidence to guide them. JAMA 2017;317(16):1611-1613 -
Medicinal cannabis: Back to the future
November 1, 2017- Archive
- Evidence Briefs
One of the arguments used by those promoting medical cannabis is that it has a long history as a therapeutic agent. Written records of its use in China date back to the first century A.D., although oral traditions suggest it was used by as early as 2700 B.C. [...] -
Cannabinoids in treatment of epilepsy (Friedman; NEJM)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Friedman D, Devinsky O. Cannabinoids in the treatment of epilepsy. N Engl J Med 2016;374(1):94-5 -
When is a prescription not a prescription?
November 1, 2017- Archive
- Evidence Briefs
Under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), physicians or nurse practitioners have the authority to write was has been broadly described as “prescriptions” for medical cannabis. But in fact, these are not prescriptions in the traditional sense. [...] -
Retrospective chart review (Slaven; J Pain Manage)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Spencer N, Shaw E, Slaven M. Medical cannabis use in an outpatient palliative care clinic: A retrospective chart review. J Pain Manage 2016;9(4):507-513 -
Medical marijuana laws and cannabis use, intersection of health and policy (Compton)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Vandrey R, Raber JC, Rabert ME et al. Cannabinoid doses and label accuracy in edible medical cannabis products. JAMA 2015;313(24):2491-2494. -
Post-traumatic stress disorder (Shalev; NEJM)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Shalev A, Liberzon I, Marmar C. Post-traumatic stress disorder. N Engl J Med 2017;376(25):2459-2469 -
Who should prescribe medicinal cannabis?
November 1, 2017- Archive
- Evidence Briefs
Who can prescribe medical cannabis varies substantially according to what country – or even what province or state – in which you live. [...] -
Adverse health effects of marijuana use (Volkow; NEJM)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med 2014;370(23):2219-27 -
What’s in your medicinal cannabis?
November 1, 2017- Archive
- Evidence Briefs
Health Canada claims it has put into place “some of the most stringent controls on the medical cannabis industry in the world.” Under these regulations, only specific pesticides and fungicides are registered for use by licensed cannabis producers. [...] -
Cannabis, cognition and addiction (Curran; Nat Rev Neurosci)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH. Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci 2016; 17(5):293- 306 -
Rheumatologists and medicinal cannabis
November 1, 2017- Archive
- Evidence Briefs
One out of every five Canadian adults 18 and older has chronic pain, and the most common cause (up to 36% of cases) is arthritis. As of 2015, almost six million Canadian adults have some form of arthritis and the number is expected to increase rapidly as the population ages. [...] -
The case of California
November 1, 2017- Archive
- Evidence Briefs
In 1996, California became the first U.S. state to legalize medical cannabis with the passage of a public referendum, Proposition 215. [...] -
Opioid guidelines (Busse)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Busse J (ed). The 2017 Canadian guideline for opioids for chronic non-cancer pain. National Pain Centre, McMaster University. 2017. -
Medicinal Marijuana for treatment of chronic pain (Hill; JAMA)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems, a clinical review. JAMA 2015;313(24):2474-83 -
Cannabis for anxiety, mood and related disorder ready for prime time? (Turna)
November 1, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know? Turna J, Patterson B, Van Ameringen M. Is cannabis treatment for anxiety, mood, and related disorders ready for prime time? Depress Anxiety 2017;doi: 1002/da.22664 (Epub ahead of print) -
The criminalization and legalization of medicinal cannabis in Canada
November 1, 2017- Archive
- Evidence Briefs
The decision to allow or not allow the use of cannabis for medical purposes in Canada is based on objective analysis of the facts, isn’t it? The truth may be surprising. [...] -
US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws (Hasin)
October 30, 2017- Archive
- Research Summaries
Why was this study conducted? What does this study add? Is there anything else I should know?